Knockdown of LKB1 Sensitizes Endometrial Cancer Cells via AMPK Activation
1Division of Translational Science, Research Institute, National Cancer Center, Goyang 10408,
2BK21 FOUR Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University, Seoul 10326, Republic of Korea
(Kim BR), email@example.com
Tel: +82-31-961-5213 (Kim BR), +82-31-961-5213 (Lee CH)
Fax: +82-31-961-5206 (Kim BR), +82-31-961-5206 (Lee CH)
Received: August 7, 2021; Revised: August 31, 2021; Accepted: September 7, 2021; Published online: October 5, 2021.
© The Korean Society of Applied Pharmacology. All rights reserved.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/
) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.